Table 3.
Univariate and multivariate analyses used for differentiating significant predictors to distinguish ancylostomiasis patients from healthy controls
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P‐value | OR | 95% CI | P‐value | |
| Gender | 1.086 | 0.679‐1.738 | 0.730 | |||
| Age (y) | 1.009 | 0.992‐1.025 | 0.139 | |||
| RBC (×1012/L) | 0.108 | 0.059‐0.197 | 0.000 | 0.047 | 0.013‐0.175 | 0.000 |
| MCV (fL) | 0.899 | 0.867‐0.933 | 0.000 | 0.016 | 0.000‐6.471 | 0.177 |
| MCH (pg) | 0.719 | 0.647‐0.800 | 0.000 | 1.790 × 105 | 0.003‐1.261 × 1013 | 0.190 |
| MCHC (g/L) | 0.898 | 0.869‐0.928 | 0.000 | 0.304 | 0.059‐1.564 | 0.154 |
| NLR | 2.372 | 1.769‐3.180 | 0.000 | 2.071 | 0.989‐4.333 | 0.053 |
| PLR | 1.025 | 1.018‐1.031 | 0.000 | 1.015 | 1.000‐1.030 | 0.053 |
| ELR | 1.134 × 107 | 0.015 × 107‐8.510 × 108 | 0.000 | 4.746 × 109 | 1.584 × 106‐1.422 × 1013 | 0.000 |
ELR, eosinophil‐to‐lymphocyte ratio; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; NLR, neutrophil‐to‐lymphocyte ratio; PLR, platelet‐to‐lymphocyte ratio; RBC, red blood cells.